How do I transfer my Triple-Negative Breast Cancer care to another hospital

Transferring Your Triple-Negative Breast Cancer Care to Another Hospital

I understand you're considering moving your care—this is an important decision, especially with triple-negative breast cancer (TNBC), which requires specialized expertise. Let me walk you through the practical steps and what you should know.

Why Transfer Might Make Sense for TNBC

Triple-negative breast cancer is aggressive and requires access to the latest treatment options. According to CancerPatientLab webinars on patient navigation, patients sometimes need to transfer care to institutions with:

• More clinical trial access
• Multidisciplinary teams (medical oncologists, surgeons, pathologists, radiologists)
• Expertise in emerging therapies for TNBC
• Better coordination between specialists

As one expert noted, "Less than 5% of cancer patients are treated through a clinical trial, which usually provide access to the standard of care plus a new and better treatment option." Major academic centers often have more trial opportunities.

Step-by-Step Transfer Process

1. **Request Your Complete [ID removed]

• Ask your current hospital for:
  • Pathology reports (especially hormone receptor and HER2 status)
  • Imaging scans (CT, MRI, PET scans)
  • Treatment records and medication lists
  • Genetic testing results (BRCA1/BRCA2 if done)
  • Lab work and blood test results
  • Surgical reports if you had surgery

Important: Request the underlying data and images, not just summaries. According to patient advocates, pathology reports sometimes lack detail. Ask specifically for: "Please provide all underlying data that informs these results, including images if available."

2. Identify Your New Hospital

Consider major academic cancer centers known for TNBC expertise:

• MD Anderson Cancer Center (Houston)
• Memorial Sloan Kettering (New York)
• Dana-Farber Cancer Institute (Boston)
• Johns Hopkins (Baltimore)
• UCSF (San Francisco)
• Fred Hutchinson (Seattle)
• Mount Sinai (New York)

These centers typically have:

• Phase 1 clinical trial programs (testing newer drugs)
• Tumor boards (multiple specialists reviewing your case)
• Access to genomic testing and personalized medicine approaches

3. Schedule a Consultation

• Contact the new hospital's breast cancer program
• Request an appointment with a medical oncologist specializing in TNBC
• Logistics: Most consultations at major centers are 1-2 day visits. You'll typically have:
  • Blood work (they usually won't repeat scans if recent)
  • Meetings with your oncologist
  • Possible meetings with phase 1 research teams
  • Discussion of clinical trial options

4. Prepare for the Appointment

Bring or have sent:

• All [ID removed] (see step 1)
• List of all medications and supplements
• Questions about your specific situation
• Any genomic testing reports (tumor sequencing, biomarker analysis)

Important Considerations for TNBC Specifically

Genomic Testing: According to breast cancer navigation resources, triple-negative patients should have:

• BRCA1/BRCA2 genetic testing (especially if diagnosed before age 60)
• Comprehensive tumor genomic analysis (whole genome sequencing or multi-gene panels)
• Ki-67 testing (measures how fast cancer cells are dividing)
• Circulating tumor DNA (liquid biopsy) tests like Signatera for monitoring treatment response

Ask your new hospital: "What genomic testing do you recommend for my triple-negative breast cancer, and which tests are covered by insurance?"

Financial & Practical Logistics

Travel & Accommodation

• Some clinical trials cover travel costs (larger companies like Bristol Myers Squibb often do; smaller companies may not)
• Ask about patient assistance programs
• Some hospitals have partnerships with local hotels for discounted rates

Insurance & Approvals

• Notify your insurance company about the transfer
• Request pre-authorization if needed
• Ask about out-of-network coverage

Coordination Between Hospitals

• Your new hospital can request records directly from your old one
• This usually takes 1-2 weeks
• You can speed this up by hand-delivering records

Questions to Ask Your New Care Team

1. "What is your experience treating triple-negative breast cancer, and what are your outcomes?"

2. "What genomic or molecular testing do you recommend for my specific case, and which tests does insurance cover?"

3. "What clinical trials am I eligible for, and how do they compare to standard treatment?"

4. "Do you have a multidisciplinary tumor board that reviews my case?"

5. "How will you monitor my response to treatment, and how often will we reassess?"

6. "What is your approach to treatment if I develop resistance to initial therapy?"

7. "Can I access telemedicine for follow-up appointments, or do I need to travel for every visit?"

Red Flags to Avoid

According to patient advocates, be cautious of providers who:

• Won't discuss treatment options beyond standard of care
• Don't offer or explain clinical trial opportunities
• Can't clearly explain your pathology results
• Don't coordinate with other specialists
• Seem rushed or unwilling to answer questions

Key Takeaway

The transfer process is straightforward, but timing matters. Don't delay if you're between treatment cycles. The best time to transfer is often:

• Before starting a new treatment line
• After completing one treatment phase
• When you have time to gather records

As emphasized in patient navigation resources: "You need multidisciplinary care: a surgeon, a radiation oncologist, a medical oncologist, a pathologist, a radiologist." Make sure your new hospital can provide this coordinated approach.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.